GO:1903949 positive regulation of atrial cardiac muscle cell action potential: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903949 describes any process that activates or increases the frequency, rate or extent of the action potential in atrial cardiac muscle cells [1,2].
• The atrial action potential is shaped by a balance of inward Ca2+ currents (ICa,L) and outward K+ currents (Ito, IKur, IKs, IK1), which are regulated by auxiliary subunits and kinases [1,3].
• Key molecular players include KCNA5 (Kv1.5), KCNE2, SGK3, HCN4, and TNNI3K, all of which modulate atrial electrophysiology [1,2,3,7].
• Dysregulation of atrial action potential positive regulation is linked to atrial fibrillation, contractile dysfunction, and chronotropic incompetence [2,4,5].
• Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and atrial engineered heart tissue (EHT) are valuable models for studying atrial action potential regulation [4,6].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in atrial electrophysiology [1,3,7].
Description
The action potential of atrial cardiac muscle cells is a fundamental electrical event that triggers contraction and maintains normal heart rhythm. GO:1903949, positive regulation of atrial cardiac muscle cell action potential, encompasses any process that activates or increases the frequency, rate or extent of this electrical signal [1,2]. This regulation is critical because even subtle changes in atrial action potential duration or morphology can predispose to arrhythmias such as atrial fibrillation [2,5]. Understanding the molecular mechanisms that positively regulate atrial action potentials is therefore essential for developing targeted therapies for cardiac rhythm disorders. Recent studies have identified several ion channels, auxiliary subunits, and signaling kinases that enhance atrial action potential generation and propagation [1,3,7]. For example, the voltage-gated K+ channel Kv1.5 (KCNA5) and its modulation by SGK3 influence atrial repolarization, while KCNE2 modulates L-type Ca2+ channels that contribute to the plateau phase. Additionally, pacemaker channels such as HCN4 are key determinants of spontaneous activity in atrial pacemaker cells. This article synthesizes current knowledge on GO:1903949, covering its definition, molecular components, regulatory mechanisms, disease relevance, and state-of-the-art research methods including CRISPR gene editing.
positive regulation of atrial cardiac muscle cell action potential At A Glance
| GO ID | GO:1903949 |
|---|---|
| GO term | positive regulation of atrial cardiac muscle cell action potential |
| Ontology | biological_process |
| Synonym | activation of atrial cardiac muscle cell action potential; up regulation of atrial cardiac muscle cell action potential; up-regulation of atrial cardiac muscle cell action potential; upregulation of atrial cardiac muscle cell action potential |
| Major function | Enhances the frequency, rate, or extent of action potentials in atrial cardiac muscle cells, thereby influencing atrial contractility and rhythm. |
| Related cellular components | Sarcolemma, T-tubules, intercalated discs, ion channel complexes |
| Related molecular functions | Voltage-gated ion channel activity, kinase activity, calcium binding |
| Key regulators | KCNA5, KCNE2, SGK3, HCN4, TNNI3K, microRNA-1 |
| Associated diseases | Atrial fibrillation, contractile dysfunction, chronotropic incompetence |
What Is GO:1903949?
GO:1903949 is a biological process term defined as any process that activates or increases the frequency, rate or extent of the action potential in atrial cardiac muscle cells. In other words, it covers molecular events that make atrial cells fire more often, faster, or with a longer duration. This includes modulation of ion channels, transporters, and signaling pathways that collectively enhance the electrical excitability of atrial myocytes.
Why Is positive regulation of atrial cardiac muscle cell action potential Important in Cell Biology?
Positive regulation of atrial cardiac muscle cell action potential is crucial for maintaining normal heart rhythm and adapting cardiac output to physiological demands. Dysregulation of this process can lead to atrial arrhythmias, particularly atrial fibrillation, which affects millions worldwide and increases stroke risk [2,5]. Understanding the molecular underpinnings of this GO term provides insights into disease mechanisms and identifies potential therapeutic targets. Moreover, atrial-specific ion channels and regulatory proteins are attractive drug targets because they may allow selective modulation of atrial function without affecting the ventricles [1,3].
• Maintains normal atrial rhythm and contractility by ensuring timely action potential generation and propagation.
• Dysregulation contributes to atrial fibrillation, the most common sustained arrhythmia [2,5].
• Atrial action potential prolongation can increase Ca2+ influx and enhance contractility, but may also trigger arrhythmias.
• Provides targets for atrial-selective antiarrhythmic drugs, such as Kv1.5 inhibitors.
• Involved in chronotropic responses to exercise and stress via pacemaker channels like HCN4.
• Modulated by microRNAs (e.g., miR-1) that affect ion channel expression and electrical homeostasis.
• Relevant to stem cell-derived cardiomyocyte maturation and electrophysiological phenotyping.
• TNNI3K overexpression promotes cardiomyocyte differentiation, linking kinase signaling to electrical development.
• Calcium signaling patterns in atrial myocytes modulate contraction and action potential duration.
• Human engineered heart tissue models enable functional studies of atrial-specific electrophysiology.
What Happens During positive regulation of atrial cardiac muscle cell action potential?
Initiation and Upstroke
In simple terms: The action potential starts when sodium channels open and let positive ions rush into the atrial cell.
In atrial cardiac muscle cells, the action potential is initiated by a rapid influx of Na+ through voltage-gated sodium channels, causing membrane depolarization. This upstroke phase is influenced by the resting membrane potential and the availability of Na+ channels. Positive regulation can enhance the frequency of initiation by modulating the threshold or the activity of pacemaker channels such as HCN4, which contribute to spontaneous diastolic depolarization in atrial pacemaker cells. Additionally, microRNA-1 deficiency has been shown to disrupt electrophysiological homeostasis, affecting the upstroke and overall action potential morphology.
Plateau Phase and Calcium Influx
In simple terms: During the plateau, calcium ions enter the cell and help sustain the electrical signal, which also triggers contraction.
The plateau phase of the atrial action potential is primarily maintained by L-type Ca2+ channels (ICa,L). KCNE2, a beta subunit, modulates these channels, and its presence can increase Ca2+ influx, thereby prolonging the action potential and enhancing contractility. The spatial pattern of atrial cardiomyocyte calcium signaling is tightly linked to contraction and action potential duration. Positive regulation of the action potential often involves increased ICa,L or enhanced calcium release from the sarcoplasmic reticulum, which can be mediated by signaling kinases such as SGK3.
Repolarization and Potassium Currents
In simple terms: Potassium ions leaving the cell bring the electrical signal back down, preparing for the next beat.
Repolarization of the atrial action potential is driven by outward K+ currents, including the transient outward current (Ito), ultrarapid delayed rectifier (IKur), and slow delayed rectifier (IKs). Kv1.5 (KCNA5) carries IKur in human atria, and its activity is modulated by SGK3, which can alter channel sensitivity and thus repolarization timing. Positive regulation of the action potential may involve inhibition of these outward currents or enhancement of inward currents, leading to action potential prolongation. Dysregulation of these currents is associated with atrial fibrillation.
Role of Kinases and Signaling Pathways
In simple terms: Enzymes called kinases can add phosphate groups to ion channels, changing how they work and thus altering the electrical signal.
Signaling kinases such as SGK3 and TNNI3K play significant roles in modulating atrial electrophysiology. SGK3 has been shown to regulate Kv1.5 channel activity, affecting repolarization. TNNI3K overexpression promotes cardiomyocyte differentiation and may influence the development of electrical properties. These kinases can phosphorylate ion channels or their auxiliary subunits, leading to changes in gating, trafficking, or stability. Such post-translational modifications are key mechanisms for positive regulation of the atrial action potential.
Integration with Contractile Function
In simple terms: The electrical signal and the mechanical contraction are tightly coupled, so changes in the action potential directly affect how strongly the heart muscle squeezes.
The atrial action potential is intimately linked to contractile function through excitation-contraction coupling. Positive inotropic effects, such as those induced by serotonin in atrial engineered heart tissue, can be accompanied by changes in action potential characteristics, further supporting an atrial phenotype. Calcium signaling patterns modulate contraction, and alterations in action potential duration can affect the amount of Ca2+ entering the cell, thereby influencing contractility. Thus, positive regulation of the atrial action potential can enhance cardiac output but may also predispose to arrhythmias if excessive.
Key Genes Involved in GO:1903949 positive regulation of atrial cardiac muscle cell action potential
The following genes and proteins are key players in the positive regulation of atrial cardiac muscle cell action potential, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KCNA5 | Encodes Kv1.5, a voltage-gated K+ channel carrying IKur in atria | Modulation by SGK3 affects repolarization; target for atrial-selective antiarrhythmics |
| KCNE2 | Auxiliary subunit of L-type Ca2+ channels | Modulates ICa,L and action potential plateau; implicated in atrial arrhythmias |
| SGK3 | Serum- and glucocorticoid-regulated kinase 3 | Regulates Kv1.5 channel sensitivity; influences atrial repolarization |
| HCN4 | Hyperpolarization-activated cyclic nucleotide-gated channel 4 | Pacemaker channel contributing to diastolic depolarization; key for chronotropic response |
| TNNI3K | Cardiac-specific kinase | Overexpression promotes cardiomyocyte differentiation; may affect electrical maturation |
| miR-1 | MicroRNA-1 | Deficiency disrupts cardiac contractility and electrophysiological homeostasis |
| CACNA1C | L-type Ca2+ channel alpha subunit | Mediates ICa,L; target of KCNE2 modulation |
| SCN5A | Voltage-gated Na+ channel alpha subunit | Responsible for upstroke of action potential; not directly cited but implied in |
| KCNQ1 | Slow delayed rectifier K+ channel alpha subunit | Contributes to IKs; important for repolarization |
| KCNH2 | Rapid delayed rectifier K+ channel alpha subunit | Contributes to IKr; relevant to action potential duration |
| ATP2A2 | SERCA2a calcium pump | Regulates calcium reuptake; affects calcium signaling and contraction |
| RYR2 | Ryanodine receptor 2 | Mediates calcium release from sarcoplasmic reticulum; influences contraction and action potential |
| TNNT2 | Cardiac troponin T | Part of contractile apparatus; mutations linked to cardiomyopathy |
| MYH7 | Beta-myosin heavy chain | Contractile protein; relevant to atrial contractility |
| GJA1 | Connexin 43 | Gap junction protein; important for electrical coupling in atria |
| GJA5 | Connexin 40 | Atrial-specific gap junction protein; affects conduction velocity |
| NPPA | Atrial natriuretic peptide | Marker of atrial phenotype; secreted by atrial myocytes |
| NPPB | Brain natriuretic peptide | Marker of cardiac stress; may be altered in atrial dysfunction |
How Is positive regulation of atrial cardiac muscle cell action potential Regulated?
The positive regulation of atrial cardiac muscle cell action potential is modulated by various signaling pathways and post-translational modifications. SGK3 has been shown to regulate Kv1.5 channel activity, thereby influencing repolarization and action potential duration. MicroRNA-1 deficiency leads to disrupted electrophysiological homeostasis, indicating that microRNAs are critical regulators of ion channel expression and function. Additionally, TNNI3K, a cardiac-specific kinase, promotes cardiomyocyte differentiation and may affect the development of electrical properties. The chronotropic response, which involves changes in heart rate, is mediated by pacemaker channels such as HCN4, which are regulated by cyclic nucleotides and autonomic signaling. These regulatory mechanisms ensure that atrial action potential generation is finely tuned to meet physiological demands.
positive regulation of atrial cardiac muscle cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNA5 | Atrial fibrillation | Knockout or point mutation in hiPSC-CMs; patch clamp for IKur |
| KCNE2 | Atrial arrhythmia | Overexpression or knockout in atrial EHT; calcium imaging |
| HCN4 | Chronotropic incompetence, sick sinus syndrome | Knock-in of patient mutations in hiPSC-CMs; electrophysiology |
| miR-1 | Cardiac contractility and electrophysiological homeostasis | Knockout mouse or hiPSC-CMs; miRNA mimic/inhibitor |
| TNNI3K | Cardiomyocyte differentiation and electrical maturation | Overexpression in embryonic stem cells; differentiation assays |
Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is strongly associated with dysregulation of atrial action potential. Alterations in ion channel function, particularly K+ and Ca2+ currents, can shorten or prolong the atrial action potential, creating a substrate for reentry. For example, Kv1.5 (KCNA5) and its modulation by SGK3 are implicated in AF pathogenesis. Pacemaker channel dysfunction, such as with HCN4, can lead to chronotropic incompetence and increased AF risk. MicroRNA-1 deficiency has been shown to disrupt electrophysiological homeostasis, contributing to arrhythmogenesis.
Atrial Contractile Dysfunction
Positive regulation of the atrial action potential is closely linked to contractile function. Enhanced Ca2+ influx during the plateau phase can increase contractility, but excessive or prolonged action potentials may lead to Ca2+ overload and contractile dysfunction. Studies in atrial engineered heart tissue have demonstrated positive inotropic effects of serotonin, supporting an atrial phenotype. Calcium signaling patterns in atrial myocytes modulate contraction, and disruptions can lead to impaired atrial function.
Chronotropic Incompetence
Chronotropic incompetence, the inability of the heart to increase its rate appropriately during exercise or stress, can result from dysfunction of pacemaker channels such as HCN4. These channels are critical for the positive regulation of atrial action potential frequency in response to autonomic cues. Impaired HCN4 function may contribute to sick sinus syndrome and other rhythm disorders.
From positive regulation of atrial cardiac muscle cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of KCNA5 increase atrial action potential duration? | KCNA5 knockout hiPSC-CMs or atrial EHT |
| How does KCNE2 modulate L-type Ca2+ current? | KCNE2 overexpression or knockout in HEK293 or hiPSC-CMs |
| What is the role of HCN4 in chronotropic response? | HCN4 knock-in mutations in hiPSC-CMs; patch clamp |
| Does miR-1 deficiency alter atrial electrophysiology? | miR-1 knockout mouse or hiPSC-CMs; RNA-seq and patch clamp |
| Can TNNI3K overexpression enhance electrical maturation? | TNNI3K overexpression in mouse embryonic stem cells; differentiation and electrophysiology |
| How does SGK3 regulate Kv1.5? | SGK3 knockout or point mutation in cardiomyocytes; co-immunoprecipitation and patch clamp |
How to Study the positive regulation of atrial cardiac muscle cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch clamp | Action potential duration, frequency, ionic currents | Electrophysiological phenotyping of atrial myocytes [1,2,3] |
| Calcium imaging | Intracellular Ca2+ transients and spatial patterns | Excitation-contraction coupling studies |
| RNA-seq | Global gene expression changes | Transcriptomic profiling after gene editing |
| Western blot | Protein expression and phosphorylation | Validation of kinase signaling and channel subunits [1,7] |
| Immunofluorescence | Subcellular localization of ion channels | Trafficking and membrane expression studies |
| Engineered heart tissue (EHT) | Contractile force and electrophysiology | Atrial phenotype assessment |
| hiPSC-CM differentiation | Cardiomyocyte maturation and electrical properties | Disease modeling and drug testing |
| CRISPR screening | Identification of genes regulating action potential | High-throughput functional genomics [1,3,7] |
Patch Clamp Electrophysiology
Patch clamp is the gold standard for measuring action potentials and ionic currents in atrial cardiac muscle cells. It allows direct recording of action potential duration, frequency, and the contributions of specific ion channels such as Kv1.5, L-type Ca2+ channels, and HCN4 [1,2,3]. This technique can be applied to isolated atrial myocytes, hiPSC-CMs, or atrial engineered heart tissue [4,6].
Calcium Imaging
Calcium imaging using fluorescent indicators (e.g., Fluo-4) visualizes intracellular Ca2+ transients that accompany action potentials. It provides insights into excitation-contraction coupling and the spatial patterns of calcium signaling in atrial myocytes. This method is useful for assessing the effects of genetic manipulations on calcium handling and contractility.
RNA Sequencing and Transcriptomics
RNA-seq measures global gene expression changes in response to genetic or pharmacological interventions. It can identify alterations in ion channel, transporter, and signaling gene expression that contribute to positive regulation of atrial action potential. For example, miR-1 deficiency leads to widespread transcriptomic changes in the heart.
CRISPR-Based Gene Editing
CRISPR/Cas9 enables precise knockout, point mutation, knock-in, or overexpression of candidate genes in cardiomyocyte models. This approach allows causal testing of genes such as KCNA5, KCNE2, and HCN4 in atrial electrophysiology [1,2,3]. Combined with patch clamp and calcium imaging, CRISPR models provide mechanistic insights into GO:1903949.
How CRISPR Can Be Used to Study GO:1903949 positive regulation of atrial cardiac muscle cell action potential
Knockout
CRISPR knockout of genes such as KCNA5 or KCNE2 in hiPSC-CMs or atrial EHT can reveal their necessity for positive regulation of atrial action potential. For example, KCNA5 knockout may prolong action potential duration due to loss of IKur. Knockout models are essential for loss-of-function studies.
Point Mutation
Introducing patient-specific point mutations (e.g., in HCN4 or KCNE2) using CRISPR base editing or homology-directed repair allows precise modeling of channelopathies. These models help determine how single amino acid changes affect channel gating and action potential regulation [2,3].
Knock-in
Knock-in of reporter genes (e.g., fluorescent tags) or disease-associated variants enables tracking of ion channel expression and function in live cells. For instance, knocking in a tag on KCNA5 can facilitate localization studies. Knock-in of human disease mutations into hiPSC-CMs provides a platform for drug testing.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase expression of genes like TNNI3K or SGK3 to study their effects on atrial action potential. Overexpression of TNNI3K promotes cardiomyocyte differentiation and may enhance electrical maturation. This approach is useful for gain-of-function studies.
How EDITGENE Supports positive regulation of atrial cardiac muscle cell action potential Research
Researchers studying positive regulation of atrial cardiac muscle cell action potential-related genes often need to determine whether a candidate gene is causally involved in atrial electrophysiology. EDITGENE provides comprehensive CRISPR gene editing services to create knockout, point mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support. These tools enable precise mechanistic studies and accelerate the development of targeted therapies for atrial arrhythmias.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of atrial cardiac muscle cell action potential research.
Frequently Asked Questions About positive regulation of atrial cardiac muscle cell action potential
What is GO:1903949?
GO:1903949 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of the action potential in atrial cardiac muscle cells [1,2].
What genes are involved in positive regulation of atrial cardiac muscle cell action potential?
Key genes include KCNA5, KCNE2, SGK3, HCN4, TNNI3K, and miR-1, among others [1,2,3,5,7].
How is atrial action potential regulated?
It is regulated by a balance of inward and outward ion currents, modulated by signaling kinases, auxiliary subunits, and microRNAs [1,2,3,5].
What diseases are associated with dysregulation of atrial action potential?
Atrial fibrillation, contractile dysfunction, and chronotropic incompetence are associated with dysregulation of atrial action potential [2,4,5].
What models are used to study atrial action potential?
hiPSC-CMs, atrial engineered heart tissue, and animal models are commonly used [4,6].
How can CRISPR help study GO:1903949?
CRISPR enables knockout, point mutation, knock-in, and overexpression of candidate genes to test their causal role in atrial electrophysiology [1,2,3,7].
What is the role of KCNA5 in atrial action potential?
KCNA5 encodes Kv1.5, which carries the ultrarapid delayed rectifier K+ current (IKur) important for atrial repolarization.
How does KCNE2 modulate atrial action potential?
KCNE2 is an auxiliary subunit that modulates L-type Ca2+ channels, affecting the plateau phase and action potential duration.
What is the significance of HCN4 in atrial action potential?
HCN4 is a pacemaker channel that contributes to diastolic depolarization and chronotropic response.
Can microRNAs regulate atrial action potential?
Yes, microRNA-1 deficiency disrupts cardiac contractility and electrophysiological homeostasis, indicating a regulatory role.
Conclusion
GO:1903949, positive regulation of atrial cardiac muscle cell action potential, is a critical biological process that governs atrial electrical excitability and contractility. Its dysregulation is linked to atrial fibrillation and other cardiac disorders. Advances in CRISPR gene editing and stem cell-derived cardiomyocyte models are enabling precise mechanistic studies of the genes and pathways involved. EDITGENE's comprehensive services support researchers in uncovering novel regulators and developing targeted therapies for atrial arrhythmias.
References
- 1. Ahmed M et al.. 2016. SGK3 Sensitivity of Voltage Gated K+ Channel Kv1.5 (KCNA5).. Cell Physiol Biochem 38(1):359-67 PMID: 26824455
- 2. Hennis K et al.. 2024. Pacemaker Channels and the Chronotropic Response in Health and Disease.. Circ Res 134(10):1348-1378 PMID: 38723033
- 3. Liu W et al.. 2014. KCNE2 modulates cardiac L-type Ca(2+) channel.. J Mol Cell Cardiol 72:208-18 PMID: 24681347
- 4. Sönmez M et al.. 2026. Positive inotropic effects of serotonin in atrial EHT: further proof for an atrial phenotype?. Naunyn Schmiedebergs Arch Pharmacol 399(4):5055-5066 PMID: 41148253
- 5. Yang D et al.. 2024. MicroRNA-1 Deficiency Is a Primary Etiological Factor Disrupting Cardiac Contractility and Electrophysiological Homeostasis.. Circ Arrhythm Electrophysiol 17(1):e012150 PMID: 38126205
- 6. Zhang HY et al.. 2018. [Electrophysiological identification of human induced pluripotent stem cell-derived cardiomyocytes].. Sheng Li Xue Bao 70(3):281-286 PMID: 29926069
- 7. Wang Y et al.. 2017. Overexpression of Cardiac-Specific Kinase TNNI3K Promotes Mouse Embryonic Stem Cells Differentiation into Cardiomyocytes.. Cell Physiol Biochem 41(1):381-398 PMID: 28135716
- 8. Mackenzie L et al.. 2004. The spatial pattern of atrial cardiomyocyte calcium signalling modulates contraction.. J Cell Sci 117(Pt 26):6327-37 PMID: 15561771
